ARXS vs TEL: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: TEL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ARXS and TEL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ARXS and TEL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Arxis, Inc. designs and manufactures specialized engineered components for demanding, mission-critical applications through two segments, Electronic Components (connectors, cable assemblies, RF and microwave products, sensors, and passives) and Mechanical Components (precision manufacturing). Its end markets split roughly across Defense and Space (around 47 percent of 2025 revenue), Commercial Aerospace (around 23 percent), and Industrial Technology (around 30 percent). The company was founded in 2019 out of predecessor businesses (including Quantic and Qnnect), backed by private-equity firm Arcline Investment Management, and is headquartered in Bloomfield, Connecticut with several thousand employees.

Full ARXS guide

TE Connectivity (NYSE: TEL) designs and manufactures connectors, sensors, and interconnect systems that move power and data through cars, factories, data centers, aircraft, appliances, and medical devices. It is the number one connector maker globally by revenue, ahead of Amphenol and Molex, and organizes its business primarily around two segments: Transportation Solutions (automotive, commercial vehicles, sensors) and Industrial Solutions (industrial equipment, energy, aerospace and defense, medical, and the fast-growing digital data networks unit that sells into AI data centers). The company is domiciled in Ireland and sells to essentially every major automaker and industrial and hyperscale customer.

Full TEL guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ARXS drivers: Defense and space exposure; Margin expansion and profitability swing.
• TEL drivers: AI data center connectivity; Vehicle electrification and content growth.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: As a company that went public only in April 2026, Arxis has a short trading history and limited public track record, which can drive volatility. For TEL, tEL's largest markets, automotive and industrial, are cyclical, so a downturn in vehicle production or capital spending can pressure revenue and margins.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ARXS if you believe its drivers more; TEL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ARXS and TEL guides.

ARXS. Arxis trades at about 41 times forward earnings, 13 times sales and roughly 46 times EV/EBITDA, multiples that price in years of acquisition-fueled and organic growth. Analysts expect 2027 EPS of about $1.32, up about 29%, and the 10 analysts Yahoo Finance tracks have a mean target near $64 versus the October 16, 2026 close of $54.03. The October 28 Q3 report, the first with the Omnetics acquisition included for most of a quarter, is the next test.

TEL. As of October 16, 2026, TEL trades near $213 per share for a market cap around $62 billion, at roughly 21 times trailing and 16 times forward earnings, a lower multiple than earlier in 2026 even as growth reached the low teens. It yields about 1.5 percent on a payout ratio near 29 percent. The analyst mean target is about $252, and the October 28 fiscal fourth-quarter report is the next catalyst.

Headline figures (approximate, October 2026): ARXS shows revenue (ttm) ~$1.77B, q2 2026 revenue growth ~25% YoY (~$501M), gross / operating margin (ttm) ~52% / ~7%, net income (ttm) ~$128M; TEL shows revenue (ttm) ~$19.3B, revenue growth (latest quarter, yoy) ~14%, quarterly sales (june 2026 quarter) ~$5.16B, operating margin ~21%.

ARXS and TEL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ARXS and TEL exposure against your real portfolio. It is not an investment adviser.